Manojna Maddipatla

Quest Diagnostics offers U.S. employers coronavirus testing as workers return

27 May 2020

Quest Diagnostics Inc on Wednesday started offering blood tests, temperature monitoring and other tailored services to U.S. employers as they attempt to reopen factories and offices after months under coronavirus-led lockdowns.

Roche's Tecentriq wins FDA approval as first-line therapy for some lung cancer forms

19 May 2020

Swiss drugmaker Roche Holding AG's Genentech unit said on Monday the U.S. Food and Drug Administration has approved Tecentriq as a standalone therapy for an advanced form of lung cancer.

COVID patients given malaria drug didn't see significant improvements - studies

15 May 2020

Patients given the malaria drug touted by President Donald Trump as a potential treatment for COVID-19 did not improve significantly over those who did not, according to two new studies published in the medical journal BMJ on Thursday.

Car rental firm Hertz raises going concern doubts as debt default looms

12 May 2020

Hertz Global Holdings Inc on Monday raised going concern doubts as the car rental company tries to cut costs and avoid debt default amid a blow to its business due to the COVID-19 pandemic, sending its shares down 4% in extended trading.

Epidemic response group to invest up to $384 mln in Novavax's COVID-19 vaccine

12 May 2020

The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $384 million to help develop and produce Novavax Inc's COVID-19 vaccine candidate, the company said on Monday, sending its shares up 31.2% in extended trading.

U.S. FDA authorizes first at-home saliva test for COVID-19

09 May 2020

The U.S. Food and Drug Administration said on Friday it has authorized the first diagnostic test for the new coronavirus that allows patients to collect saliva samples at-home.

UPDATE 2-Novartis prices lung cancer drug at $17,950 for 28-day supply

07 May 2020

May 6 Novartis AG on Wednesday priced its treatment for a hard-to-treat form of lung cancer at the U.S. wholesale acquisition cost of $17,950 for a 28-day supply, following the drug's approval by regulators.

Cigna confident of meeting 2021 profit target despite virus-led crisis

30 Apr 2020

Cigna Corp on Thursday reaffirmed its profit goals for this year and the next, expecting its $52 billion acquisition of pharmacy benefits manager Express Scripts to tide over the COVID-19-triggered global economic meltdown.

Anthem sees more people opting for government plans as coronavirus hammers job market

29 Apr 2020

Anthem Inc said on Wednesday that the COVID-19 pandemic could trigger a big shift in business mix and push more people into Medicaid or Obamacare health plans from employer-sponsored ones due to job losses across industries.

Centene maintains 2020 outlook, but warns of higher medical costs

28 Apr 2020

Centene Corp on Tuesday reiterated its profit target for 2020, but warned of higher medical costs in the second half of the year expecting its members to resume their elective health care procedures postponed due to the COVID-19 pandemic.

World News